Enjoy complimentary customisation on priority with our Enterprise License!
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Etiology
06.1.1 Male Infertility Etiology
06.1.2 Pre-testicular
06.1.3 Testicular
06.1.4 Post-testicular
06.1.5 Others
06.1.6 Female Infertility Etiology
06.1.7 Female Infertility associated with Anovulation
06.1.8 Female Infertility of Tubal Origin
06.1.9 Female Infertility of Uterine Origin
06.1.10 Female Infertility of Other Origin
06.1.11 Female Infertility, Unspecified
06.2 Signs and Symptoms
06.2.1 Male Infertility Signs and Symptoms
06.2.2 Female Infertility Signs and Symptoms
06.3 Treatment
06.3.1 Treatment for Male Infertility
06.3.2 Treatment for Female Infertility
06.3.3 Reproductive Assistance
06.4 Tests and Diagnosis
06.4.1 Male: Tests and Diagnosis
06.4.2 Female: Tests and Diagnosis
06.4.3 Prevalence
07. Country Overview
07.1.1 US
07.1.2 UK
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Type
09.1.1 Infertility Drugs
09.1.2 Infertility Devices
09.2 Global Infertility Drugs Market
09.2.1 Market Size and Forecast
09.3 Global Infertility Devices Market
09.3.1 Market Size and Forecast
10. Market Segmentation by Underlying Cause
11. Geographical Segmentation
11.1 Infertility Market in Americas
11.1.1 Market Size and Forecast
11.2 Infertility Market in APAC Region
11.2.1 Market Size and Forecast
11.3 Infertility Market in EMEA Region
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Licensing and Collaborations
19.1.3 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Bayer HealthCare
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical Segmentation by Revenue 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 CooperSurgical
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Business Segmentation by Revenue
20.2.5 Business Segmentation by Revenue 2012 and 2013
20.2.6 Business Strategy
20.2.7 Key Developments
20.2.8 SWOT Analysis
20.3 Ferring Pharmaceuticals
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 SWOT Analysis
20.4 Merck & Co. Inc.
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2013
20.4.4 Business Segmentation by Revenue 2012 and 2013
20.4.5 Sales by Geography
20.4.6 Business Strategy
20.4.7 Key Developments
20.4.8 SWOT Analysis
21. Other Reports in this Series
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.